Loading...

PBYI PUMA BIOTECHNOLOGY INC Management Changes 8-K Filing

PM B

PBY

PUMA BIOTECHNOLOGY INC

(PBYI)

2025 8-K

Financial Results

Financial Statements

Amendments to Bylaws

Financial Statements

Financial Results

Q3 Financial Results

Patent Infringement Case

Patent Infringement Case

Lawsuit against AstraZeneca...

Earnings Report

Annual Meeting Approval

Lawsuit against AstraZeneca...

Earnings Reports

Lawsuit against AstraZeneca

Earnings Report

Presentation at Oncology Co...

Earnings Reports

Acceptance of Trial at Conf...

Bylaws Amendment

Earnings Report

Annual Meeting of Stockholders

Earnings Report

Earnings Report

Regulation FD Disclosure

External Links:

On June 19, 2025, Puma Biotechnology, Inc. revised its Fourth Amended and Restated Bylaws to align with updates to Delaware law, incorporating various conforming changes. This filing is part of routine corporate governance updates.

AI Assistant

PUMA BIOTECHNOLOGY INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.